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Background/Objectives: The concept of dynapenic obesity has been gaining great attention recently.
However, there is little epidemiological evidence demonstrating that dynapenic abdominal obese in-
dividuals have worse trajectories of disability than those with dynapenia and abdominal obesity alone.
Our aim was to investigate whether dynapenia combined with abdominal obesity can result in worse
trajectories of instrumental activities of daily living (IADL) among English and Brazilian older adults over
eight and ten years of follow-up, respectively.
Methods: We used longitudinal data from 3374 participants from the English Longitudinal Study of
Ageing (ELSA) and 1040 participants from the Brazilian Health, Well-being and Aging Study (SABE) who
were free from disability as assessed by IADL at baseline. IADL disability was deﬁned herein as a difﬁculty
to perform the following: preparing meals, managing money, using transportation, shopping, using the
telephone, house cleaning, washing clothes, and taking medications according to the Lawton IADL
modiﬁed scale. The study population in each country was categorized into non-dynapenic/non-
abdominal obese (reference group), abdominal obese, dynapenic and dynapenic abdominal obese ac-
cording to their handgrip strength (<26 kg for men and <16 kg for women) and waist circumference
(>102 cm for men and >88 cm for women). We used generalized linear mixed models with IADL as the
outcome.
Results: The estimated change over time in IADL disability was signiﬁcantly higher for participants with
dynapenic abdominal obesity compared to those with neither condition in both cohorts (ELSA: þ0.023,
95% CI ¼ 0.012e0.034, p < 0.001; SABE: þ0.065, 95% CI ¼ 0.038e0.091, p < 0.001). Abdominal obesity
was also associated with changes over time in IADL disability (ELSA: þ0.009, 95% CI ¼ 0.002e0.015,
p < 0.05; SABE: þ0.021, 95% CI ¼ 0.002e0.041, p < 0.05), which was not observed for dynapenia.
Conclusions: Abdominal obesity is an important risk factor for IADL decline but participants with
dynapenic abdominal obesity had the highest rates of IADL decline over time among English and Bra-
zilian older adults.
© 2017 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Muscle strength and muscle mass decline with aging, but het-
erogeneously in different groups [1]. The complete mechanism that, Federal University of S~ao
65-905, S~ao Carlos, S~ao Paulo,
dre).
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dults, Clinical Nutrition (2017explains this decline and how it affects the muscle function is not
fully understood [2,3]. In contrast, there is strong evidence linking
low muscle strength with incident mobility limitation, disability in
instrumental and basic activities of daily living, and mortality
[4e11].
This age-related decline inmuscle strength andmusclemass has
been accompanied by increasing obesity in older adults globally
[12]. The increase in adiposity as a risk factor to low muscle
strength and disability and the relationship between adipose tissueunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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The body fat distribution changes with aging resulting in an in-
crease in central adiposity and fat deposition in muscle while there
is a reduction in subcutaneous fat [20,21]. Recent evidence has
shown that fatty inﬁltration of muscle is an important component
of low muscle strength and that abdominal obesity can reduce
muscle strength through inﬂammatory and endocrine mechanisms
[18e21].
Few studies have investigated the combined associations of
abdominal obesity and dynapenia on incident disability [22e25].
The fact that previous studies have analyzed obesity and dynapenia
as independent conditions, without taking into account that they
can occur simultaneously in older adults, ignores the possibility
that strength decline may be associated with obesity. Furthermore,
this approach may lead to an overestimation of the association
between dynapenia and abdominal obesity with disability.
Therefore, the main aim of this study was to analyze whether
dynapenia combined with abdominal obesity was associated with
worse trajectories of instrumental activities of daily living (IADL)
disability among English and Brazilian older adults who were free
from disability, as measured by instrumental activities of daily
living, at baseline over a period of eight- and ten-years of follow-up
respectively.
2. Methods
Data were extracted from the English Longitudinal Study of
Ageing (ELSA) and from the Brazilian Health, Well-being and Aging
Study (SABE). ELSA is a panel study that began in 2002 with a
representative sample of older English adults aged 50 years and
over. After baseline, follow-up interviews within ELSA occur every
two years and health examinations (i.e. a nurse visit), every four
years. SABE is a panel study that began in 2000 with a represen-
tative sample of older adults living in Sao Paulo, Brazil, aged 60
years and over. Further information on study design and sampling
of both cohorts can be found elsewhere [26,27].
Participants aged 60 years and older in 2004 for ELSA, when
anthropometric data were collected for the ﬁrst time, and in 2000
for SABE were included in this analysis. In ELSA, of 6180 partici-
pants interviewed in 2004 with information on instrumental ac-
tivities of daily living (IADL), 1657 were excluded because they
reported at least one disability in IADL at baseline, 1116 were
excluded due to missing data for handgrip strength, waist
circumference or other covariates, and 33 were excluded due to
being underweight (BMI < 18.5 kg/m2), resulting in a ﬁnal analyt-
ical sample of 3374 individuals. In SABE, of 2142 participants
interviewed in 2000 with IADL information, 863 were excluded
because they reported at least one disability in IADL at baseline, 212
were excluded due to missing data for the reasons described above,
and 27 were excluded due to being underweight, resulting in a ﬁnal
analytical sample of 1040 individuals. In both of our studies, the
handgrip strength and waist circumference measurements were
not undertaken for participants who were unable to be in a
standing position or were incapable of performing the handgrip
test. Underweight older adults were excluded to avoid bias in our
results since underweight is an important risk factor for IADL
limitation [28].
In ELSA, selected participants were reassessed in 4 and 8 years of
follow-up while in SABE they were reassessed in 5 and 10 years of
follow-up.
2.1. Ethics approval and informed consent
Written informed consent was obtained from all ELSA and SABE
participants. The National Research Ethics Service (LondonPlease cite this article in press as: Alexandre TdS, et al., The combinat
trajectories of IADL disability among older adults, Clinical Nutrition (201Multicenter Research Ethics Committee (MREC/01/2/91)) approved
the English Longitudinal Study of Ageing. The Brazilian Human
Research Ethics Committee approved Health, Well-being and Aging
Study (MS/315/99).
2.2. IADL assessment
IADL disability was measured at baseline and at each follow-up
visit, in both studies.
Disability was deﬁned herein as a self-reported difﬁculty to
perform the following: preparing meals, managing money, using
transportation, shopping, using the telephone, house cleaning,
washing clothes, and taking medications according to the Lawton
IADL modiﬁed scale [29,30]. Eight items were summed to form a
scale that ranged from 0 to 8, with 0 representing no disability in
IADL. In this analysis, we included only individuals without any
IADL disability at baseline.
2.3. Anthropometric measurements and classiﬁcation of the groups
A trained evaluator carried out the waist circumference mea-
surement with a ﬂexible tape placed at the midpoint between the
iliac crest and the last rib. Participants remained upright with the
arms alongside the body and without the upper portion of their
clothes and were instructed to relax the abdomen and the measure
was taken at the end of the expiratory phase of a breathing cycle. A
waist circumference >88 cm for women and >102 cm for men was
considered as abdominal obesity [31].
Grip strength measurements were obtained by a hand held
dynamometer (Takei Kiki Kogyio TK 1201 in SABE and Smedley in
ELSA). Maximum strength tests were performed with a 1-min rest
between tests and the highest value was used. Dynapenia was
deﬁned based on two cutoff points for grip strength: <16 kg for
women and <26 kg for women [32].
We constructed a four-category time varying variable, based on
participants' dynapenia and abdominal obesity status at each visit.
The categories were as follows: non dynapenic/non abdominal
obese; abdominal obese only; dynapenic only; and dynapenic
abdominal obese. Thus, an individual could be abdominal obese but
non dynapenic at one visit and acquire dynapenia at the next. In
such circumstances, he/she would be “abdominal obese alone” and
“dynapenic abdominal obese” respectively.
2.4. Covariates
Covariates included in our analyses were sociodemographic,
behavioral characteristics and clinical conditions.
Sociodemographic covariates were age, sex, marital status, in-
come and level of education. Age was categorized into three 10-
year age groups. Participants aged 80 years and older were com-
bined into a single age group. Marital status was deﬁned as married
(married participants or those in a stable relationship) and not
married (separated, divorced or widowed). Socioeconomic status
and educational level were measured distinctly in ELSA and SABE.
In ELSA, we used household wealth quintiles. Total non-pension
household wealth included ﬁnancial wealth (investments and
savings), the value of any business assets, the value of any home
and other property (less mortgage), and physical wealth such as
jewelry and artwork, net of debt. The three-way educational clas-
siﬁcation was used to analyze ELSA data: a level lower than “O-
level” or equivalent (0e11 schooling years), a level lower than “A-
level” or equivalent (12e13 schooling years), and a higher qualiﬁ-
cation (>13 schooling years). For SABE participants, the Brazilian
monthlyminimumwage in 2000 (R$151.00¼US$ 84.7) was used to
calculate income which was further categorized into three bands:ion of dynapenia and abdominal obesity as a risk factor for worse
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169.41e423.5) and more than ﬁve times the minimum wage
(US$ > 423.5). Educational level (in years) was analyzed as a
continuous variable.
Smoking status was assessed by asking participants whether
theywere a current smoker, former smoker or non-smoker. Alcohol
consumption was classiﬁed as drank never or rarely (even once a
week), frequently (2e6 times a week) or daily in both studies. In
ELSA, three self-reported questions on the frequency (more than
once per week, once per week, one to three times per month, or
hardly ever) of participation in vigorous, moderate, and mild
physical activities (PA) were used, and two PA groups were created:
sedentary lifestyle (no physical activity on a weekly basis), and
active (mild, moderate or vigorous physical activity at least once a
week). In SABE, sedentary lifestylewas deﬁned as a physical activity
level less than three times a week in the last year.
Systemic arterial hypertension, cancer, diabetes, heart disease,
lung disease, stroke, osteoarthritis, falls and hospitalization in the
previous 12 months were recorded based on self-reports. Hospitali-
zation was not measured in ELSA. Depressive symptoms were
deﬁned by the Center for Epidemiologic Studies Depression Scale
(CESD) score  4 in ELSA and by the 15-item Geriatric Depression
Scale (GDS) score  5 in SABE. Due to the low level of education
among theSABEparticipants, cognitionwasassessedby themodiﬁed
version of theMini Mental State Exam (MMSE). This measure has 13
itemswith a possible total score of 19 points that donot dependupon
schooling. Cognitive impairmentwasdeﬁned as a score of12points
[33]. In ELSA cognition function was assessed by verbal memory, i.e.
immediate and delayed recall. It was assessed by presenting to par-
ticipants a list of 10 nouns aurally on a computer, one every 2 s. As
manywords as possible recalled immediately, and after a short delay
during which participants carried out the other cognitive tests, were
recorded. An overall memory score ranging from 0 to 20 using both
the immediate- anddelayed-recall resultswas computed. Bodymass
index (BMI) was obtained by dividing weight in kilograms by height
in meters squared (kg/m2) and used as continuous variable. Self-
reported near and far vision (good/regular/poor) and hearing
(good/regular/poor) were also included in our analyses.
All the covariates included in our analyses represent a broad
spectrum of risk factors associated with the progression of IADL
disability [30]. All variables were treated in our analyses as time-
varying covariates, with the exception of age, sex and level of
education.
2.5. Statistical analyses
Means, standard deviations (continuous variables) and per-
centages (categorical variables) were reported for descriptive data
at baseline. Differences in baseline characteristics between: (1)
included and excluded individuals (due to missing data on hand-
grip strength, waist circumference or other covariates), and (2) the
four analytical groups classiﬁed on the basis of participants'
dynapenia and abdominal obesity status, were assessed using chi
square tests, analysis of variance and post hoc Tukey tests. A p
value < 0.05 was used to indicate statistical signiﬁcance.
Cognitive function, income and level of education were
considered in this analysis as important risk factors for examining
changes in IADL disability over time. As information on these var-
iables was not harmonized, the trajectories of IADL disability were
analyzed separately in ELSA and SABE cohorts in order to maintain
these important covariates in our models.
To estimate the trajectories in IADL disability we used general
linear mixed models using the XTMIXED procedure in Stata 14® SE
program (StataCorp, College Station, TX). These models were cho-
sen because they best handle unbalanced data from studies withPlease cite this article in press as: Alexandre TdS, et al., The combinat
trajectories of IADL disability among older adults, Clinical Nutrition (2017repeated measures, and they enable the statistical modeling of
changes in a time-dependent outcome variable (IADL score), as well
as allowing time-dependent change in the magnitude of associa-
tion between variables [34,35].
Since all participants were free from IADL disability at the
baseline visit, the estimates from the mixed models represent the
estimated change in IADL score over a follow-up period of one year
(i.e. a one-unit increase in time).
We entered a time by dynapenia/abdominal obesity status
interaction term into our models to estimate the difference in the
change in IADL score for a one-unit increase in time between the
dynapenic abdominal obese group and the reference group (neither
dynapenia nor abdominal obesity). Similar comparisons to the
reference group were made for the dynapenia only and abdominal
obesity only groups. The interactions terms therefore enable the
pace of change in the IADL score over the follow-up period to vary
across the four dynapenia/abdominal obesity groups.
We ﬁtted a series of ﬁve sequential models. The unadjusted
model (Model 1) contained just the time by dynapenia/abdominal
obesity status interaction term. Model 2 was additionally adjusted
for socioeconomic covariates. Model 3 was additionally adjusted for
behavioral characteristics, Model 4 was additionally adjusted for
clinical conditions, and Model 5 was additionally adjusted for BMI
since both BMI and waist circumference have been associated with
disability [36,37]. The time interactions represent the difference in
the annual rate of change (slope) between particular dynapenic
abdominal obese group and the reference (neither dynapenia nor
abdominal obesity) in disability.
In order to establish whether the association of dynapenia and
abdominal obesity only on the trajectories of IADL disability could
be overestimated a sensitivity analysis was performed by entering
these two variables separately in the models, i.e. dynapenia (no/
yes) and abdominal obesity (no/yes).
3. Results
Of the 3374 participants at baseline with no IADL disability and
complete data on all covariates in ELSA, 2619 and 2243 were
reassessed at 4 and 8 years of follow-up, respectively. Of the 1040
participants at baseline in SABE, 657 and 488 were reassessed at 5
and 10 years of follow-up. Baseline sociodemographic, behavioral
and clinical characteristics of both cohorts according to the dyna-
penia and abdominal obesity groups are shown in Tables 1 and 2.
In our analyses which compared included and excluded in-
dividuals by missing data in handgrip strength, waist circumfer-
ence and other covariates (but all IADL disability free at baseline)
the excluded participants in both studies were found to have lower
BMI and worse cognitive function. Furthermore, in ELSA, the
excluded participants were older, had lower handgrip strength,
lower level of education and wealth, living without a partner,
smokedmore, drank less alcohol, reportedmore sedentary lifestyle,
falls, stroke, were more depressed and had worse vision while, in
SABE, they had lower waist circumference (p < 0.05) (Supplemental
Table 1).
The prevalence of dynapenic abdominal obesity at baseline was
3.6% (95% CI 3.0e4.3) in ELSA and 6.9% (95% CI 5.4e8.6) in SABE.
3.7% (95% CI 3.1e4.4) of individuals in ELSA were dynapenic
compared with 9.4% (95% CI 7.6e11.3) in SABE. In ELSA 46.3% (95%
CI 44.6e48.0) were abdominal obese while 41.4% (95% CI
38.4e44.5) had this condition in SABE. The prevalence of non-
dynapenic/non-abdominal obese was 46.4% (95% CI 44.7e48.1) in
ELSA and 42.3% (95% CI 39.3e45.4) in SABE.
Table 3 shows the fully adjusted general linear mixed models
estimated parameters for the change over time in IADL scores as a
function of dynapenia and abdominal obesity status over the 8-yearion of dynapenia and abdominal obesity as a risk factor for worse
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Table 1
Baseline sociodemographic and behavioral characteristics of 3374 older adults from the ELSA Study (2002) and 1040 elderly from SABE Study (2000) according abdominal
obesity and dynapenia status.
Non-Dynapenic Non-Abdominal Obese Abdominal Obese Dynapenic Dynapenic Abdominal Obese
ELSA n ¼ 1564
SABE n ¼ 440
ELSA n ¼ 1563
SABE n ¼ 431
ELSA n ¼ 125
SABE n ¼ 97
ELSA n ¼ 122
SABE n ¼ 72
Sociodemographic variables
Age, years
ELSA 70.9 ± 6.9 71.2 ± 6.5 78.7 ± 8.5a,b 76.5 ± 9.0a,b,c
SABE 70.0 ± 7.0 69.3 ± 7.0 75.5 ± 7.5a,b 73.8 ± 7.5a,b,c
Sex (female), (%)
ELSA 47.8 56.2a 52.0 63.1a
SABE 36.6 70.1a 23.7a,b 80.6a,c
Marital status (married), (%)
ELSA 71.2 70.6 55.2a,b 54.9a,b
SABE 68.2 53.6a 63.9 38.9a,b,c
Income SABE, (%)
US$  169.4 28.6 30.9 37.1 54.2a,b,c
>US$ 169.4 and US$  423.5 30.7 26.7 34.0 20.8a,b,c
>US$ 423.5 27.5 23.9 19.6 8.3a,b,c
Unreported 13.2 18.5 9.3 16.7a,b,c
Household wealth ELSA, (%)
5st quintile (highest quintile) 9.5 14.3a 24.0a,b 15.6a,b
4nd quintile 15.0 18.2a 22.4a,b 27.1a,b
3th quintile 20.3 22.6a 15.2a,b 22.1a,b
2th quintile 23.3 22.0a 23.2a,b 26.2a,b
1th quintile (lowest quintile) 30.7 21.9a 14.4a,b 8.2a,b
Unreported 1.2 1.0a 0.8a,b 0.8a,b
Schooling ELSA, (%)
Higher than A level 29.2 22.2a 18.4a 9.0a,b
0 level or equivalent 25.5 22.1a 16.0a 19.7a,b
Less than 0 level or equivalent 45.3 55.7a 65.6a 71.3a,b




ELSA 41.0 35.7a 31.2 36.1
SABE 42.1 60.6a 48.4 75.0a,c
Ex-smoker
ELSA 48.1 53.4a 57.6 54.9
SABE 37.0 29.5a 36.1 20.8a,c
Current smoker
ELSA 10.9 10.9a 11.2 9.0
SABE 20.9 9.9a 15.5 4.2a,c
Alcohol consumption, (%)
Drank never or rarely
ELSA 32.4 41.2a 40.8 50.8a,b
SABE 81.1 91.2a 74.2b 95.8a,c
Drank frequently
ELSA 46.5 40.9a 43.2 39.3a,b
SABE 9.6 5.1a 12.4b 1.4a,c
Drank daily
ELSA 21.1 17.9a 16.0 9.9a,b
SABE 9.3 3.7a 13.4b 2.8a,c
Sedentary lifestyle
ELSA 1.6 1.9 4.0a 4.1a
SABE 61.8 70.5a 77.3a 68.1
Data are presented as proportions, means and standard deviation. aSigniﬁcantly different from non-dynapenic/non-abdominal obese; bSigniﬁcantly different from abdominal
obese; cSigniﬁcantly different from dynapenic. Statistical signiﬁcance was set as p < 0.05. NA: Not available.
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the estimated change over time in IADL score was stable for the
reference group (when all covariates were zero or at average values).
In other words, according to the estimated coefﬁcients, there was no
signiﬁcant decline in IADL score over time for the following in-
dividuals: aged 60e69 years old, males, with higher schooling and
those who remained non-dynapenic/non-abdominal obese, mar-
ried, household wealth ¼ 5th quintile, non-smokers, non-drinkers,
non-sedentary lifestyle, no hypertension, no diabetes, no cancer, no
lung and heart disease, no stroke, no osteoarthritis, no falls, good
perception of vision and hearing, with CESD score <4 points, Mean
Memory Score ¼ 20, and BMI ¼ 18.5 kg/m2 over time.
Dynapenic abdominal obese participants had a signiﬁcantly
higher rate of increase in IADL disability trajectory over 8-yearsPlease cite this article in press as: Alexandre TdS, et al., The combinat
trajectories of IADL disability among older adults, Clinical Nutrition (201compared to those who were non-dynapenic non-abdominal
obese. The parameter estimate for the difference in slopes
was þ0.023 IADL points per year (95% CI ¼ 0.012e0.034) after
adjusting for socioeconomic and behavioral characteristics, clinical
conditions and BMI (Table 3, Model 5).
For SABE, the estimated change over time in IADL score was also
stable for participants in the reference group. In other words, ac-
cording to the estimated coefﬁcients there was no signiﬁcant
decline in IADL score over time for the following individuals: aged
60e69 years old, males, with schooling ¼ 16 years and those who
remained non-dynapenic/non-abdominal obese, married, income
5 Brazilianmonthlyminimum salary, non-smokers, non-drinkers,
non-sedentary lifestyle, no hypertension, no diabetes, no cancer, no
lung and heart disease, no stroke, no osteoarthritis, no falls, noion of dynapenia and abdominal obesity as a risk factor for worse
7), https://doi.org/10.1016/j.clnu.2017.09.018
Table 2
Baseline clinical characteristics of 3374 older adults from the ELSA Study (2002) and 1040 elderly from SABE Study (2000) according abdominal obesity and dynapenia status.
Non-Dynapenic Non-Abdominal Obese Abdominal Obese Dynapenic Dynapenic Abdominal Obese
ELSA n ¼ 1564
SABE n ¼ 440
ELSA n ¼ 1563
SABE n ¼ 431
ELSA n ¼ 125
SABE n ¼ 97
ELSA n ¼ 122
SABE n ¼ 72
Clinical conditions
Arterial hypertension (yes), (%)
ELSA 14.8 21.6a 16.0 22.1a
SABE 39.8 55.5a 33.0b 65.3a,c
Diabetes (yes), (%)
ELSA 2.2 4.4a 1.6 5.7a
SABE 10.5 19.5a 13.4 22.2a
Cancer (yes), (%)
ELSA 2.6 4.3a 3.2 1.6
SABE 2.7 3.0 1.0 8.3a,b,c
Lung disease (yes), (%)
ELSA 9.9 13.0a 15.2 14.8
SABE 10.0 7.4 7.2 1.4a
Heart disease (yes), (%)
ELSA 7.2 9.3a 12.0 11.5
SABE 12.3 15.1 13.4 20.8a
Stroke (yes), (%)
ELSA 0.8 0.7 0.8 1.6
SABE 3.6 3.3 0.1 5.6c
Osteoarthritis, (%)
ELSA 24.7 34.9a 52.0a,b 62.3a,b
SABE 16.6 29.9a 18.6b 30.6a
Falls (yes), (%)
ELSA 23.9 26.9 29.6 33.6a
SABE 22.5 27.8 25.8 31.9
Hospitalization (yes), (%)
ELSA NA NA NA NA
SABE 2.7 3.3 3.1 4.2
Mean Memory Score ELSA, points 10.2 ± 3.2 9.9 ± 3.2a 8.4 ± 3.7a,b 8.2 ± 3.6a,b
Mini Mental State Exam (12 points), (%)
SABE 2.7 2.1 6.2b 6.9b
Depression, (%)
ELSA 6.6 10.2a 16.8a,b 14.8a
SABE 13.2 12.8 8.3 13.9
Perception of hearing, (%)
Good
ELSA 80.0 80.0 73.6a 78.7c
SABE 71.4 76.6 70.1 77.8
Regular
ELSA 16.5 15.7 18.4a 20.5c
SABE 24.5 19.9 21.7 19.4
Poor
ELSA 3.5 4.3 8.0a 0.8c
SABE 4.1 3.5 8.2 2.8
Perception of vision (%)
Good
ELSA 91.1 90.5 82.4a,b 83.6a,b
SABE 13.6 9.5 14.5 11.1
Regular
ELSA 7.5 8.3 15.2a,b 16.3a,b
SABE 40.7 46.9 41.2 51.4
Poor
ELSA 1.4 1.2 2.4a,b 0.1a,b
SABE 45.7 43.6 44.3 37.5
Handgrip strength, kg
ELSA 32.4 ± 9.9 31.6 ± 9.9a 16.1 ± 5.9a,b 15.2 ± 5.3a,b
SABE 30.2 ± 8.0 26.6 ± 8.1a 19.3 ± 4.7a,b 14.5 ± 4.3a,b,c
Waist circumference, cm
ELSA 87.3 ± 8.7 103.6 ± 9.7a 85.6 ± 8.9a.b 103.0 ± 10.1a,c
SABE 87.4 ± 8.6 102.8 ± 9.2a 87.4 ± 8.3a,b 100.3 ± 8.4a,c
Body Mass Index, kg/m2
ELSA 24.8 ± 2.5 30.5 ± 3.9a 24.2 ± 2.6a,b 30.3 ± 4.1a,b,c
SABE 23.9 ± 2.6 29.7 ± 4.0a 23.2 ± 2.5a,b 28.3 ± 3.3a,b,c
Data are presented as proportions, means and standard deviation. aSigniﬁcantly different from non-dynapenic/non-abdominal obese; bSigniﬁcantly different from abdominal
obese; cSigniﬁcantly different from dynapenic. Statistical signiﬁcance was set as p < 0.05. NA: Not available.
T.S. Alexandre et al. / Clinical Nutrition xxx (2017) 1e9 5hospitalization, good perception of vision and hearing, with GDS
score 5 points, MMSE 13 points, and BMI ¼ 18.5 kg/m2 over
time.
Dynapenic abdominal obese participants had signiﬁcantly
higher rate of increase in IADL disability trajectory over 10-yearsPlease cite this article in press as: Alexandre TdS, et al., The combinat
trajectories of IADL disability among older adults, Clinical Nutrition (2017than the participants who were non-dynapenic non-abdominal
obese. The parameter estimate for the difference in slopes
was þ0.065 IADL points per year (95% CI ¼ 0.038e0.091) after
adjusting for socioeconomic and behavioral characteristics, clinical
conditions and BMI (Table 3, Model 5).ion of dynapenia and abdominal obesity as a risk factor for worse
), https://doi.org/10.1016/j.clnu.2017.09.018
Table 3
General linear mixedmodels estimates for IADL score as a function of dynapenia and abdominal obesity status over a 8-year period in English older adults (N¼ 3374) and over a
10-year period in Brazilian older adults (N ¼ 1040).
ELSA Model 1 Model 2 Model 3 Model 4 Model 5
Parameter Estimated (Lower to Upper 95% CI)
N ¼ 3374 N ¼ 3374 N ¼ 3374 N ¼ 3374 N ¼ 3374
Time, years 0.036 (0.030e0.042)* 0.004 (0.007e0.016) 0.007 (0.006e0.020) 0.002 (0.012e0.016) 0.002 (0.014e0.017)
Time  ND/NAO Reference Reference Reference Reference Reference
Time  AO 0.008 (0.002e0.015)* 0.007 (0.001e0.014)* 0.010 (0.004e0.016)* 0.009 (0.003e0.015)* 0.009 (0.002e0.015)*
Time  D 0.015 (0.004e0.026)* 0.005 (0.017e0.007) 0.001 (0.011e0.013) 0.002 (0.014e0.010) 0.005 (0.017e0.007)
Time  D/AO 0.037 (0.027e0.048)** 0.025 (0.013e0.037)** 0.030 (0.019e0.042)** 0.028 (0.017e0.039)** 0.023 (0.012e0.034)**
SABE N ¼ 1040 N ¼ 1040 N ¼ 1040 N ¼ 1040 N ¼ 1040
Time, years 0.124 (0.103e0.144)** 0.091 (0.048e0.135)** 0.085 (0.035e0.134)** 0.054 (0.015e0.092)* 0.037 (0.039e0.112)
Time  ND/NAO Reference Reference Reference Reference Reference
Time  AO 0.015 (0.007e0.038) 0.011 (0.012e0.034) 0.018 (0.004e0.040) 0.019 (0.002e0.037)* 0.021 (0.002e0.041)*
Time  D 0.063 (0.039e0.087)** 0.051 (0.027e0.075)** 0.053 (0.029e0.076)** 0.002 (0.018e0.021) 0.005 (0.024e0.015)
Time  D/AO 0.092 (0.061e0.123)** 0.077 (0.046e0.108)** 0.060 (0.030e0.090)** 0.065 (0.040e0.090)** 0.065 (0.038e0.091)**
*p< 0.05; **p < 0.001. There is no term representing differences in the IADL score at baseline as all participants had no IADL disability. The terms represents differences in slope
between the group in question and the reference.Model 1e Unadjusted model;Model 2e Adjusted by socioeconomic characteristics;Model 3 e Adjusted by socioeconomic
and behavioral characteristics; Model 4 e Adjusted by socioeconomic, behavioral and clinical characteristics; Model 5 e Adjusted by socioeconomic, behavioral, clinical
characteristics and Body Mass Index. ND/NAO: Non dynapenic/non abdominal obese; AO: Abdominal obese only; D: Dynapenic only; D/AO: Dynapenic/Abdominal obese.
Fig. 1. Trajectories of IADL disability according to dynapenia and abdominal obesity
T.S. Alexandre et al. / Clinical Nutrition xxx (2017) 1e96Our sensitivity analyses showed that by not combining dynapenia
and abdominal obesity, and not adjusting for BMI, could result in an
overestimation of the parameters for abdominal obesity and dyna-
penia only on the trajectory of IADL disability in both studies. The
models inour sensitivityanalysiswhichadjusted for BMI also showed
an overestimation of the parameters on the trajectories of IADL
disability for abdominal obesity, but the parameter for dynapenia
became statistically insigniﬁcant in both studies. This reinforces the
importance of the analytical approach adopted in our study: i.e. to
consider the combined associations of abdominal obesity and dyna-
penia on incident disability whilst adjusting for BMI (Table 4).
Summarizing, in both the ELSA and SABE cohorts, the estimated
IADL disability trajectory in those participants with dynapenic
abdominal obesity increased more rapidly over time compared to
those with neither condition (Figs. 1 and 2). Although slightly
overlapping (as shown in Figs. 1 and 2), compared to those par-
ticipants with neither condition, participants in both the ELSA and
SABE cohorts with abdominal obesity only (but not with dynapenia
only) had worse trajectories of IADL disability.status e ELSA study 2004e2012. Predictions for age 60e69, male, married, household
wealth ¼ 5th quintile, schooling ¼ higher than A level, drank never or rarely, never
smoked, no sedentary lifestyle, no hypertension, no diabetes, no cancer, no lung dis-
ease, no heart disease, no stroke, no osteoarthritis, no falls, good perception of vision,
good perception of hearing, CESD <4 points, Mean Memory Score ¼ 20 and body mass
index ¼ 18.5 kg/m2.4. Discussion
Our main ﬁndings showed that dynapenic abdominal obese
older adults had worse trajectories of IADL disability over time thanTable 4
General linear mixed models estimate for IADL score as a function of dynapenia and abdominal obesity status over an 8-year period in English older adults (N¼ 3374) and over
a 10-year period in Brazilian older adults (N ¼ 1040) e Sensitivity Analysis.
Explanatory variable Model 1 Model 2 Model 3 Model 4 Model 5
Parameter Estimated (Lower to Upper 95% CI)
ELSA N ¼ 3374 N ¼ 3374 N ¼ 3374 N ¼ 3374 N ¼ 3374
Time, years 0.035 (0.029e0.040)** 0.003 (0.009e0.015) 0.006 (0.007e0.019) 0.001 (0.013e0.015) 0.001 (0.015e0.017)
Time  Abdominal Obesity 0.010 (0.004e0.016)** 0.010 (0.004e0.016)* 0.012 (0.006e0.018)** 0.012 (0.006e0.018)** 0.011 (0.005e0.017)**
Time  Dynapenia 0.023 (0.015e0.030)** 0.008 (0.001e0.016) 0.012 (0.004e0.021)* 0.010 (0.002e0.018)* 0.006 (0.002e0.014)
SABE N ¼ 1040 N ¼ 1040 N ¼ 1040 N ¼ 1040 N ¼ 1040
Time, years 0.122 (0.102e0.143)** 0.090 (0.047e0.134)** 0.085 (0.035e0.135)** 0.052 (0.014e0.091)* 0.032 (0.044e0.108)
Time  Abdominal Obesity 0.019 (0.001e0.039) 0.015 (0.005e0.036) 0.015 (0.004e0.035)** 0.029 (0.013e0.045)** 0.031 (0.013e0.050)**
Time  Dynapenia 0.068 (0.048e0.089)** 0.056 (0.037e0.076)** 0.049 (0.029e0.068) 0.018 (0.002e0.034)* 0.013 (0.003e0.029)
*p < 0.05; **p < 0.001. There is no term representing differences in the IADL score at baseline as all participants had no IADL disability. The terms represent differences in slope
between the group in question and the reference.Model 1e Unadjusted model;Model 2e Adjusted by socioeconomic characteristics;Model 3 e Adjusted by socioeconomic
and behavioral characteristics; Model 4 e Adjusted by socioeconomic, behavioral and clinical characteristics; Model 5 e Adjusted by socioeconomic, behavioral, clinical
characteristics and Body Mass Index.
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Fig. 2. Trajectories of IADL disability according to dynapenia and abdominal obesity
status e SABE study 2000e2010. Predictions for age 60e69, male, married,
income > US$ 423.5, schooling ¼ 16 years, drank never or rarely, never smoked, no
sedentary lifestyle, no hypertension, no diabetes, no cancer, no lung disease, no heart
disease, no stroke, no osteoarthritis, no falls, no hospitalization in previous 12 months,
good perception of vision, good perception of hearing, GDS <5 points, MMSE 13
points and body mass index ¼ 18.5 kg/m2.
T.S. Alexandre et al. / Clinical Nutrition xxx (2017) 1e9 7non-dynapenic non-abdominal obese individuals. Abdominal
obesity only was associated with these trajectories in both English
and Brazilian older adults, which was not observed for dynapenia
only.
Previous research has found associations between dynapenic
abdominal obesity and poorer physical function or disability but
none, however, analyzed trajectories. For example, Bouchard et al.
analyzing 2039 American men and women aged 55 years and over
found in a cross-sectional analysis that dynapenic abdominal
obesity was associated with poorer physical function than obesity
only and dynapenia only [22]. Rossi et al. using data from 93 to 169
Italianwomen and men respectively aged between 66 and 78 years
from 11 general practitioners found that the risk of worsening
disability was higher among dynapenic abdominal obese in-
dividuals compared to those who were non-dynapenic non-
abdominal obese [23]. Stenholm et al. analyzing six years of follow-
up data from 930 individuals aged 65 years and over from Italy
found that obesity (BMI  30 kg/m2) combined with low muscle
strength increased the rate of decline in walking speed. These in-
dividuals also developed mobility disability, especially those
younger than 80 years [24]. Finally, Batsis et al. analyzing 2025
subjects with knee osteoarthritis aged 60 years and over during
four years of follow-up in the US, found that obesity only
(BMI  30 kg/m2), dynapenia only, and dynapenic obesity was
associated in both genders with reduced gait speed at baseline,
with the dynapenic obese group presenting the worse perfor-
mance. At baseline and over the study period, dynapenic obese
men had worse performance in a 400-m walking test [25].
The relationship between muscle strength and adiposity is
dependent on the measure of obesity used i.e. BMI or waist
circumference. Recently, a cross-sectional analysis by Keevil et al.
using data from 8441 women and men, aged between 48 and 92
years, from the European Prospective Investigation into Cancer-
Norfolk, found that a larger body mass index was associated with
higher grip strength. However, high waist circumference was
associated with weaker grip strength. Furthermore, they showed
that for every 10 cm increase in waist circumference, grip strength
was 3.56 kg lower in men and 1.00 kg lower inwomen. The authors
suggested that abdominal fat is the most metabolically active tissuePlease cite this article in press as: Alexandre TdS, et al., The combinat
trajectories of IADL disability among older adults, Clinical Nutrition (2017providing a potential mechanism for the association between
skeletal muscle and adiposity [38].
It is plausible to assume that increases in central obesity could
negatively affect muscle strength with the dynapenic-abdominal
obesity group presenting worse IADL disability trajectories. This
mechanism is not fully explained, but there is some evidence to
support it. For example, adipokines have been shown to be asso-
ciated with energy balance, immune-modulation, fatty acid and
glucosemetabolism and inﬂammatory responses. Physiological and
molecular studies have demonstrated receptors to adiponectin and
leptin on skeletal muscle cells and shown that their activation
promotes decreases in fatty acid deposition, increases the insulin
sensitivity and fatty acid oxidation of muscle tissue. However, in
obese individuals, skeletal muscle appears to develop resistance to
adiponectin and leptin and circulating levels of adiponectin addi-
tionally decline [39]. These effects increase skeletal muscle insulin
resistance and associated with high expression of circulating cy-
tokines as TNF-a, TNF-b and IL-6, promoted by abdominal obesity,
increasing muscle catabolic activity [40]. In addition, TNF is also
responsible for depressing the anabolic process and reduce the
effect on myelination and repair of damaged axons through
reduction of the effects mediated by the insulin-like growth factor-
1 (IGF-1) [41]. Moreover, intra- and inter-muscular fat inﬁltration
affecting muscular anatomy and impairing its function has been
associated to obesity, particularly to abdominal obesity [42e46].
This study presents some evidence to support the notion that
choosing not to separate dynapenic abdominal obesity participants
from those with dynapenia and abdominal obesity only leads to an
overestimation of the association of these two conditions with
worse trajectories of IADL disability. These ﬁndings highlight that
these changes to body composition can happen simultaneously in
later life and are important risk factors for incident disability in
these populations.
Several strengths and potential limitations of our study need to
be acknowledged. The ﬁrst strength is the use of easy tools to detect
abdominal obesity and dynapenia in clinical practice. Second, the
study used data from two large samples of community-dwelling
older adults from a developed and developing country with a
long period of follow-up. Third, we adjusted ourmixedmodels for a
large group of confounding variables associated with IADL
disability. Finally, the trajectory analyses were conducted on in-
dividuals who were IADL disability free at baseline, allowing us to
estimate the associations of these risk factors on IADL disability
over time. The identiﬁcation of potential risk factors could lead to
the development of public health strategies to prevent, delay and
treat IADL disability.
We would like to acknowledge some limitations. The drop-out
rate due to follow-up could be a source of bias. However, this
type of bias is unavoidable in longitudinal studies of aging that only
include community-dwelling older adults. A further limitation re-
lates to the generalizability of our ﬁndings. For example, the
disability trajectories of those individuals experiencing cognitive
decline in our analyses may be underestimated due to the fact that
those participants excluded from our analysis had worse cognitive
function than those included in our analytical samples. Similarly,
the exclusion of participants who were underweight at baseline
may have led to an overestimation of the trajectories for obesity.
However, despite the differences between the included and
excluded participants in both cohorts with respect to a number of
covariates, we were still able to observe signiﬁcantly worse
disability trajectories for dynapenic obese individuals and for those
with abdominal obesity only among Brazilian and English older
adults. Finally, the lack of information, in both cohorts, about diet,
history of obesity, age of onset of obesity and number of years being
overweight is also a limitation.ion of dynapenia and abdominal obesity as a risk factor for worse
), https://doi.org/10.1016/j.clnu.2017.09.018
T.S. Alexandre et al. / Clinical Nutrition xxx (2017) 1e985. Conclusions
Abdominal obesity is an important risk factor for IADL decline
but participants with dynapenic abdominal obesity had the highest
rate of IADL decline over time among English and Brazilian older
adults. Our ﬁndings highlight the clinical importance of including
abdominal obesity and dynapenia in the assessment of disability
risk among older adults, particularly when both conditions are
present in the same patient and independently of BMI. Therefore,
since abdominal obesity and dynapenia are potentially modiﬁable
risk factors, our ﬁndings indicate potential paths for preventing or
at least delaying the IADL disability process in older adults.
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